文献速递头颈外科

头颈癌决策中的个体化预后咨询:一项非随机临床试验

Individualized Prognostic Counseling for Decision-Making in Head and Neck Cancer: A Nonrandomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-01-01

该前瞻性非随机临床试验纳入458例初诊可治愈的头颈鳞状细胞癌患者,比较标准咨询与额外个体化预后咨询(基于在线预后模型)对决策的影响。结果显示个体化预后咨询与决策冲突和决策后悔降低相关,并促进患者更主动和共享的决策角色,但生活质量无相关差异。

要点

  • 个体化预后咨询可降低小喉癌和其他头颈癌患者的决策冲突。
  • 个体化预后咨询与3-6个月时决策后悔降低相关,12个月时差异极小。
  • 个体化预后咨询与其他头颈癌患者更主动或共享的决策角色相关。

核心结论

  • 基于在线预后模型的个体化预后咨询与头颈癌患者决策冲突和决策后悔改善相关,并促进更主动和共享的决策角色。

研究设计与样本

  • 前瞻性非随机临床试验,序贯队列设计,在学术三级转诊中心开展。
  • 共纳入458例初诊原发头颈鳞状细胞癌且适合治愈性治疗的患者,队列1(2014年1月至2018年8月)258例接受标准咨询,队列2(2019年10月至2022年1月)200例接受额外个体化预后咨询。
  • 平均(SD)年龄66.1(8.8)岁,79%(362/458)为男性。

主要发现

  • 个体化预后咨询后决策冲突在小喉癌组(Cohen d=0.19;95%CI,-0.10至0.49)和其他头颈癌组(Cohen d=0.34;95%CI,0.10-0.58)均降低。
  • 其他头颈癌组中,决策冲突量表的信息、价值观清晰和支持子量表效应量最大且最精确。
  • 个体化咨询后3-6个月决策后悔降低:小喉癌组队列2中位数5(IQR,0-20) vs 队列1中位数20(IQR,1-29),rank-biserial r=0.15;其他头颈癌组队列2中位数10(IQR,0-20) vs 队列1中位数20(IQR,10-25),rank-biserial r=0.29。
  • 12个月时上述差异极小。
  • 其他头颈癌组观察到个体化咨询与更主动或共享决策角色相关(Cramer V=0.21)。

临床怎么用

  • 可考虑将基于在线预后模型的个体化预后信息整合到常规咨询中,以增强患者参与、加强共享决策并减少复杂治疗选择中的不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Managing head and neck squamous cell carcinoma (HNSCC) involves complex decision-making, requiring a balance between optimizing prognosis and preserving quality of life. However, the role of individualized prognostic counseling in the decision-making process is not well known. OBJECTIVE: To assess the association of individualized prognostic counseling with the decision-making process in patients with primary HNSCC. DESIGN, SETTING, AND PARTICIPANTS: This prospective nonrandomized clinical trial with sequential cohorts was conducted at an academic tertiary referral center. Patients with newly diagnosed primary HNSCC who were eligible for curative treatment were enrolled between January 2014 and August 2018 (cohort 1; standard) and between October 2019 and January 2022 (cohort 2; intervention). Data were analyzed between January and August 2023. INTERVENTION: Cohort 1 received standard counseling from the treating physician, while cohort 2 received additional individualized prognostic counseling through an online prognostic model. Both cohorts were divided into small laryngeal squamous cell carcinoma (SLSCC) and other HNSCC groups. MAIN OUTCOMES AND MEASURES: The primary outcome was decisional conflict, measured using the Decisional Conflict Scale. Secondary outcomes included perceived role in decision-making (Control Preferences Scale), decisional regret, treatment choice, and quality of life. RESULTS: A total of 458 patients were enrolled (258 in cohort 1 and 200 in cohort 2; mean [SD] age, 66.1 [8.8] years; 79% [362 of 458] men). Decisional conflict was lower following individualized prognostic counseling for both SLSCC (Cohen d = 0.19; 95% CI, -0.10 to 0.49) and other HNSCC groups (Cohen d = 0.34; 95% CI, 0.10-0.58). Among patients with other HNSCC, the largest and most precise effect sizes were seen in the informed, values clarity, and support subscales of the Decisional Conflict Scale. Decisional regret was lower at 3 to 6 months after individualized counseling (cohort 2 median, 5 [IQR. 0-20] and cohort 1 median, 20 [IQR, 1-29]; rank-biserial r = 0.15 for SLSCC; cohort 2 median, 10 [IQR. 0-20] and cohort 1 median, 20 [IQR, 10-25]; rank-biserial r = 0.29 for other HNSCC), indicating small to moderate improvements. These differences were minimal at 12 months. An association between individualized counseling and more active or shared decision-making roles was observed in the other HNSCC group (Cramer V = 0.21). No relevant differences in quality-of-life outcomes were identified. CONCLUSIONS AND RELEVANCE: This nonrandomized clinical trial found that individualized prognostic counseling with an online prognostic model was associated with improvements in decisional conflict and decisional regret and promoted a more active and shared decision-making role among patients with head and neck cancer. The findings suggest integrating individualized prognostic information into routine consultations may enhance patient engagement, strengthen shared decision-making, and reduce uncertainty in complex treatment choices. TRIAL REGISTRATION: Dutch Trial Register: NTR4106.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Dorr MC, Hoesseini A, Sewnaik A, et al. Individualized Prognostic Counseling for Decision-Making in Head and Neck Cancer: A Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 41481329. doi:10.1001/jamaoto.2025.4838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。